We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $27.7B Turnover 6.77%
1-Year Est. Return 52.44%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+52.44%
3 Year Est. Return
+92.17%
5 Year Est. Return
+120.28%
10 Year Est. Return
+519.8%
AUM
$10B
AUM Growth
+$518M
Cap. Flow
-$105M
Cap. Flow %
-1.05%
Top 10 Hldgs %
18.87%
Holding
233
New
8
Increased
78
Reduced
133
Closed
4
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
2.4 years

Sector Composition

Rank Sector Weight
1 Financials 23.16%
2 Industrials 19.65%
3 Technology 15.19%
4 Healthcare 13.48%
5 Consumer Discretionary 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SEE icon
76
DELISTED
Sealed Air
SEE
$51.7M 0.52%
1,210,506
-2,502
-0.2% -$111K
2013 Q4
15 quarters
OIS icon
77
Oil States International
OIS
$478M
$50.9M 0.51%
2,009,633
+23,545
+1% +$579K
2017 Q2
1 quarter
DRI icon
78
Darden Restaurants
DRI
$24.1B
$50.9M 0.51%
645,892
-14,277
-2% -$1.2M
2013 Q4
15 quarters
ITUB icon
79
Itaú Unibanco
ITUB
$106B
$47.9M 0.48%
7,206,021
-176,678
-2% -$1.08M
2013 Q4
15 quarters
MAS icon
80
Masco
MAS
$14.2B
$47.4M 0.47%
1,214,627
+8,281
+0.7% +$312K
2013 Q4
15 quarters
KEY icon
81
KeyCorp
KEY
$21.4B
$47.1M 0.47%
2,502,890
+41,027
+2% +$742K
2013 Q4
15 quarters
BCR
82
DELISTED
CR Bard Inc.
BCR
$45.7M 0.46%
142,593
-4,948
-3% -$1.58M
2013 Q4
15 quarters
PDCE
83
DELISTED
PDC Energy, Inc.
PDCE
$45.4M 0.45%
926,952
+3,460
+0.4% +$149K
2016 Q1
6 quarters
EMN icon
84
Eastman Chemical
EMN
$7.3B
$44.6M 0.44%
493,285
+421
+0.1% +$35.8K
2013 Q4
15 quarters
CSX icon
85
CSX Corp
CSX
$89.9B
$44.1M 0.44%
2,438,619
-52,035
-2% -$893K
2013 Q4
15 quarters
ATVI
86
DELISTED
Activision Blizzard
ATVI
$44M 0.44%
681,570
-113,390
-14% -$7.07M
2013 Q4
15 quarters
MPT icon
87
Medical Properties Trust
MPT
$1.85B
$43.2M 0.43%
3,292,875
+64,512
+2% +$831K
2013 Q4
15 quarters
MOH icon
88
Molina Healthcare
MOH
$11B
$42.6M 0.42%
620,278
-5,617
-0.9% -$366K
2014 Q2
13 quarters
VWR
89
DELISTED
VWR Corporation
VWR
$42.5M 0.42%
1,282,785
-475,275
-27% -$15.7M
2016 Q3
4 quarters
ASX icon
90
ASE Group
ASX
$106B
$42.2M 0.42%
6,828,995
-2,085,199
-23% -$13.1M
2013 Q4
15 quarters
RNR icon
91
RenaissanceRe
RNR
$14.4B
$41.8M 0.42%
309,180
-2,965
-0.9% -$417K
2013 Q4
15 quarters
EGP icon
92
EastGroup Properties
EGP
$10.5B
$41.1M 0.41%
+466,484
New +$40.3M
2017 Q3
0 quarters
HII icon
93
Huntington Ingalls Industries
HII
$10.5B
$38.4M 0.38%
169,589
+5,142
+3% +$1.07M
2013 Q4
15 quarters
TSM icon
94
TSMC
TSM
$2.14T
$37.9M 0.38%
1,008,956
-797,252
-44% -$29.1M
2014 Q4
11 quarters
PGR icon
95
Progressive
PGR
$127B
$37.3M 0.37%
771,192
-19,972
-3% -$934K
2013 Q4
15 quarters
FLEX icon
96
Flex
FLEX
$34.3B
$37.3M 0.37%
2,984,699
-64,390
-2% -$794K
2013 Q4
15 quarters
BA icon
97
Boeing
BA
$147B
$36.6M 0.36%
143,928
-8,924
-6% -$2.08M
2013 Q4
15 quarters
PENN icon
98
PENN Entertainment
PENN
$2.02B
$36.5M 0.36%
+1,562,359
New +$33.5M
2017 Q3
0 quarters
GD icon
99
General Dynamics
GD
$91.7B
$36.1M 0.36%
175,377
-8,600
-5% -$1.72M
2013 Q4
15 quarters
AKAM icon
100
Akamai
AKAM
$12.6B
$35.9M 0.36%
737,501
-17,046
-2% -$815K
2013 Q4
15 quarters

Similar funds

EARNEST Partners's Q3 2017 Portfolio in Review

As of Q3 2017, EARNEST Partners held 233 positions worth $10B, up 5.4% from $9.52B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

EARNEST Partners's Q3 2017 filing shows 8 new, 78 increased, 133 reduced and 4 closed positions. Its largest new stake was Darling Ingredients: 3,984,504 shares worth $69.8M. The largest sale was Teva Pharmaceutical Industries Limited, an estimated $99.4M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • EARNEST Partners's largest Q3 2017 buy was Darling Ingredients: 3,984,504 shares worth $69.8M.
  • EARNEST Partners added most to Core Laboratories in Q3 2017, an estimated $11.2M increase.
  • EARNEST Partners's biggest Q3 2017 reduction was TSMC, cutting an estimated $29.1M.
  • EARNEST Partners fully exited Teva Pharmaceutical Industries Limited in Q3 2017, selling an estimated $99.4M.
  • EARNEST Partners's ten largest holdings make up 19% of its $10B portfolio in Q3 2017.
  • EARNEST Partners opened 8 new positions and closed 4 in Q3 2017.
  • EARNEST Partners's portfolio value rose 5.4% quarter-over-quarter to $10B.

Based on EARNEST Partners's 13F filing for Q3 2017, filed 14 Nov 2017.